Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Posted on by ScienceFather

Mr. Agete Tadewos Hirigo | Medicine and Dentistry | Excellence in Research Award

Hawassa University, Ethiopia

Dr. Agete Tadewos Hirigo is an Assistant Professor at Hawassa University in Ethiopia, specializing in clinical chemistry and medical laboratory sciences. With a robust academic background and extensive research experience, he has significantly contributed to the fields of metabolic disorders, infectious diseases, and clinical diagnostics. Dr. Hirigo has authored over 40 peer-reviewed publications, reflecting his commitment to advancing medical science and improving healthcare outcomes in Ethiopia and beyond.

Professional Profile

Education

Dr. Hirigo’s academic journey began with a Diploma in Medical Laboratory Technology from Addis Ababa University in 2000. He then earned a BSc in Medical Laboratory Technology Sciences from Hawassa University in 2009. In 2012, he completed his MSc in Clinical Laboratory Sciences (Clinical Chemistry) at the University of Gondar. Currently, he is pursuing a PhD in Clinical Nutrition at Addis Ababa University, demonstrating his dedication to continuous learning and specialization in his field.

Professional Experience

Dr. Hirigo’s professional career spans over two decades. He started as a Senior Lab Technologist at Hawassa University Comprehensive Specialized Hospital from 2009 to 2011. He then served as an Expert Clinical Chemist from 2012 to 2015. From 2015 to 2019, he was a Lecturer at the School of Medical Laboratory Sciences, Hawassa University. Since July 2019, he has been serving as an Assistant Professor, where he is involved in lecturing, research, student supervision, and quality assurance in clinical chemistry laboratories.

Research Interests

Dr. Hirigo’s research interests are diverse and impactful. He focuses on metabolic disorders such as dyslipidemia and metabolic syndrome, particularly among HIV-infected and psychiatric patients. His work also encompasses the study of antiretroviral therapy effects, infectious diseases like hepatitis B and C, and public health issues such as hand hygiene practices among schoolchildren. His research aims to address critical health challenges in Ethiopia, contributing to evidence-based interventions and policies.

Research Skills

Dr. Hirigo possesses a comprehensive skill set in clinical laboratory sciences. His expertise includes laboratory diagnostics, clinical chemistry, and the use of statistical tools like SPSS for data analysis. He is proficient in designing and conducting cross-sectional and cohort studies, laboratory quality assurance, and instrument maintenance. His skills are instrumental in both academic research and practical laboratory settings, ensuring high standards of laboratory services and research outputs.

Awards and Honors

While specific awards and honors are not detailed in the available information, Dr. Hirigo’s extensive publication record and academic positions indicate recognition in his field. His involvement in significant research projects and collaborations with other institutions reflect his esteemed status in the academic and medical communities.

Conclusion

Dr. Agete Tadewos Hirigo exemplifies the qualities of a dedicated researcher and educator. His extensive experience, diverse research interests, and commitment to improving healthcare through science make him a valuable asset to the medical community. His work not only advances scientific knowledge but also has practical implications for public health in Ethiopia. Dr. Hirigo’s ongoing contributions continue to inspire and influence the field of clinical laboratory sciences.

Publications Top Notes

📘 1. Rivaroxaban in Rheumatic Heart Disease–Associated Atrial Fibrillation
Authors: SJ Connolly, G Karthikeyan, M Ntsekhe, A Haileamlak, A El Sayed, …
Journal: New England Journal of Medicine, 387(11), 978–988 (2022)
Citations: 200
🔬 Major randomized trial comparing rivaroxaban and vitamin K antagonists in RHD-AF.

📘 2. Hyperuricemia and Metabolic Syndrome in Type 2 Diabetes Mellitus Patients at Hawassa University
Authors: SB Woyesa, AT Hirigo, TB Wube
Journal: BMC Endocrine Disorders (2017)
Citations: 96
🧪 Correlation study of uric acid levels and metabolic syndrome in diabetic patients.

📘 3. Prevalence of Dyslipidemia Among HIV-Infected Patients Using First-Line HAART
Authors: A Tadewos, Z Addis, H Ambachew, S Banerjee
Journal: AIDS Research and Therapy (2012)
Citations: 91
🩺 Comparative cross-sectional analysis in Southern Ethiopia.

📘 4. Burden of Metabolic Syndrome Among HIV-Infected Patients in Southern Ethiopia
Authors: DY Tesfaye, S Kinde, G Medhin, YC Megerssa, A Tadewos, E Tadesse, …
Journal: Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 8(2), 102–107 (2014)
Citations: 84
🧬 Assessment of metabolic complications among PLHIV on ART.

📘 5. Hepatitis B Virus Among Pregnant Women in Yirgalem Hospital, Ethiopia
Authors: A Amsalu, G Ferede, S Eshetie, A Tadewos, D Assegu
Journal: Journal of Pregnancy (2018), Article ID: 8435910
Citations: 78
👶 Implication of HBV screening for preventing mother-to-child transmission.

📘 6. The INVICTUS Rheumatic Heart Disease Research Program
Authors: G Karthikeyan, SJ Connolly, M Ntsekhe, A Benz, S Rangarajan, G Lewis, …
Journal: American Heart Journal, 225, 69–77 (2020)
Citations: 52
🫀 Study design for comparing rivaroxaban vs. VKA in RHD.

📘 7. Gender Influence in Metabolic Syndrome Among PLHIV on ART
Authors: AT Hirigo, DY Tesfaye
Journal: BMC Research Notes (2016)
Citations: 45
📊 Exploration of sex-based differences in ART-related metabolic issues.

📘 8. Length of Stay in Emergency Departments in Southern Ethiopia
Authors: GH Alemu, KG Negari, KM Rodamo, AT Hirigo
Journal: BMC Research Notes (2019)
Citations: 43
🏥 Study of variables influencing emergency department stay duration.

📘 9. Hand Washing Practices Among Primary Schoolchildren in Yirgalem
Authors: D Eshetu, T Kifle, AT Hirigo
Journal: Journal of Multidisciplinary Healthcare (2020), 759–768
Citations: 36
🧼 KAP study on hygiene practices among schoolchildren.

📘 10. Coinfections with Hepatitis B, C, and Syphilis Among HIV Patients
Authors: T Shimelis, Y Tassachew, A Tadewos, MW Hordofa, A Amsalu, …
Journal: HIV/AIDS – Research and Palliative Care
Citations: 33
⚕️ Cross-sectional data on coinfection rates in PLHIV.

 

Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Posted on by ScienceFather

Assist. Prof. Dr. Mohamed Nasreldin | Medicine and Dentistry | Excellence in Research Award

Consultant Nephrologist from Imam Abdulrahman Bin Faisal, Saudi Arabia

Dr. Mohamed Ahmed Nasreldin is an American consultant internist and nephrologist currently serving as Assistant Professor at King Fahad Hospital of the University (KFHU), Dammam, Saudi Arabia. With over 16 years of clinical experience, he has demonstrated exceptional competence in both internal medicine and nephrology, managing complex cases with compassion, precision, and interdisciplinary collaboration. Dr. Nasreldin holds a rich academic background complemented by international qualifications and fellowships, including the prestigious Fellow of the American Society of Nephrology (FASN). His work spans clinical care, teaching, and research, particularly in dialysis, kidney transplantation, and interventional nephrology. A committed educator, he has contributed significantly to medical education by tutoring nephrology fellows and mentoring residents and medical students. His fluency in Arabic, English, and Russian enhances his ability to connect across cultures and deliver impactful education and care. Dr. Nasreldin has received several awards and certificates of appreciation for his excellence in research presentations, academic contributions, and leadership in clinical practice. With a strong foundation in research and clinical trials, he has authored multiple peer-reviewed publications and continues to contribute to national and international nephrology forums. His career reflects a balanced dedication to patient care, clinical innovation, and academic leadership.

Professional Profile

Education

Dr. Mohamed Ahmed Nasreldin has pursued a comprehensive and international academic journey in medicine and nephrology. He holds a PhD in Clinical Nephrology (2016–2019) from UCN, USA, and a Clinical MD in Internal Medicine from Odessa State Medical University, Ukraine (2005–2009). He also earned an MBBS with honors in Medicine and Surgery from the same institution. His postgraduate education includes an MSc in Renal Medicine and a Postgraduate Diploma in Renal Medicine from the University of South Wales, UK. Dr. Nasreldin’s credentials also include the European Specialty Examination in Nephrology (ESENeph), jointly administered by the UEMS and the Royal College of Physicians, UK, along with a Fellowship from the American Society of Nephrology (FASN) awarded in 2019. His education is further supported by numerous certifications from globally recognized institutions, such as Johns Hopkins University (clinical research), the University of Leiden (kidney and pancreas transplantation), and the Royal College of Physicians, UK (renal medicine). In addition, he has completed specialized training in kidney pathology, gout management, and ADPKD treatment. This robust academic foundation not only underpins his clinical and research proficiency but also reflects his commitment to lifelong learning and evidence-based practice.

Professional Experience

With 16 years of experience in internal medicine and nephrology, Dr. Mohamed Nasreldin has established himself as a highly competent and dedicated clinician. He began his medical career with a residency program at Odessa State Medical University, where he gained extensive exposure to various subspecialties. Since 2009, he has been an integral part of the internal medicine department at King Fahad Hospital of the University (KFHU), Saudi Arabia. In this role, he manages both inpatient and outpatient care, including hemodialysis and peritoneal dialysis patients, and is actively involved in hospital consultations and on-call duties. Dr. Nasreldin’s clinical expertise covers a broad spectrum, from acute kidney injury and chronic kidney disease to renal transplantation and interventional nephrology. In addition to his clinical responsibilities, he plays a pivotal role in medical education and training. He tutors nephrology fellows, mentors residents, and delivers lectures to undergraduate and postgraduate students. His leadership in clinical care, education, and patient safety has been consistently recognized by peers and institutional authorities. Known for his problem-solving abilities under pressure, team collaboration, and organizational skills, Dr. Nasreldin continues to contribute significantly to both patient outcomes and the development of future nephrologists.

Research Interests

Dr. Mohamed Nasreldin’s research interests lie primarily in clinical nephrology, with a strong focus on dialysis modalities, renal transplantation, and interventional nephrology. He is particularly passionate about improving outcomes for patients on peritoneal dialysis and exploring patient-centered decision-making processes in renal care. His doctoral research examined the use of prophylactic antibiotics in end-stage renal disease (ESRD) patients undergoing colonoscopy while on automated peritoneal dialysis—a prospective randomized controlled trial that reflects his commitment to optimizing clinical protocols through evidence-based research. Dr. Nasreldin is also interested in transplant nephrology, including the management of acute and chronic allograft nephropathy, and the development of new catheter insertion techniques. His research extends to diabetes-related kidney disease, endothelial dysfunction in ischemic heart disease, and innovative strategies in nephrology education and practice. He has actively participated in clinical trials, presented findings at national and international conferences, and published research aimed at improving therapeutic outcomes in nephrology. As a mentor, he supervises clinical research for residents and fellows, fostering an academic environment that values inquiry and innovation. His dedication to research enhances his clinical practice, ensuring that patients benefit from the most current and effective medical interventions.

Research Skills

Dr. Nasreldin possesses a well-rounded set of research skills developed over more than a decade of conducting clinical investigations in internal medicine and nephrology. He is experienced in the design, monitoring, and execution of clinical trials, particularly randomized controlled studies that assess new interventions in renal care. His skills encompass the formulation of research hypotheses, patient recruitment and consent, data collection and analysis, and the interpretation of clinical findings for publication and presentation. Dr. Nasreldin is also proficient in guiding research as a supervisor and mentor, especially for nephrology fellows and internal medicine residents. His methodological strengths include statistical analysis, critical appraisal of the literature, and integration of research into clinical practice. Additionally, his ability to present research findings at scientific forums and publish in peer-reviewed journals underscores his communication and academic writing abilities. He is trained in research ethics and regulatory compliance, having completed a clinical research certificate from Johns Hopkins University. His involvement in various educational workshops and clinical symposiums enhances his collaborative research experience. These research skills have enabled him to contribute significantly to medical knowledge in nephrology, while also improving clinical decision-making and patient outcomes.

Awards and Honors

Dr. Mohamed Nasreldin has been recognized multiple times for his contributions to nephrology through awards and certificates of appreciation, reflecting both his clinical excellence and academic achievements. Notably, he received a Certificate of Appreciation at the First Gulf Peritoneal Dialysis Forum in Oman (2024) and won first place for poster presentation at the ISN-EMAN Update Congress in Nephrology, Dubai (2017). His oral presentation on acute kidney injury at the Saudi International Congress of Nephrology and Transplantation (2018) earned commendation, as did his role as a speaker at the International Conference of Diabetes and Its Complications in Baltimore (2017). He was honored by the nephrology division at King Fahad Hospital of the University for upholding high standards of care aligned with JCI requirements. Additionally, his participation in public awareness events, such as World Kidney Day, and academic initiatives like the 3rd Annual Research Day at King Saud University (2012), further illustrate his professional commitment. These accolades emphasize his role as a thought leader in nephrology, combining research, clinical practice, and public engagement. The consistent recognition from national and international platforms affirms Dr. Nasreldin’s impact on advancing kidney health and medical education.

Conclusion

Dr. Mohamed Ahmed Nasreldin stands out as a distinguished clinician, educator, and researcher in the field of nephrology, making him a strong candidate for the Excellence in Research Award. His extensive academic background, including a PhD in clinical nephrology and fellowship with the American Society of Nephrology, lays the foundation for his clinical acumen and research productivity. With over 16 years of experience, Dr. Nasreldin has shown exemplary commitment to improving patient outcomes, mentoring the next generation of physicians, and contributing to the scientific community. His research spans dialysis innovations, kidney transplantation, and interventional nephrology, all grounded in real-world clinical challenges. While his scholarly output could benefit from more high-impact journal publications and international collaborations, his existing contributions and active engagement in medical forums are noteworthy. Dr. Nasreldin’s work aligns closely with the criteria for the Excellence in Research Award—particularly through his original investigations, teaching impact, and patient-centered clinical innovations. His trajectory reflects a blend of practical application and academic inquiry, reinforcing his value to the nephrology community. Continued institutional support and broader research dissemination could further enhance his profile, making him not only a deserving recipient but also a future leader in academic nephrology.

Publications Top Notes

  1. An update on sickle cell nephropathy
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 25(2), 249–265
    Year: 2014
    Citations: 54

  2. The use of SGLT2 inhibitors in peritoneal dialysis patients: a shade of light on dapagliflozin
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, M.A. Nasreldin, A.M. Mohammed, …
    Journal: Archives of Nephrology and Urology, 5(1), 1–8
    Year: 2022
    Citations: 15

  3. Pregnancy in peritoneal dialysis and an infant with a ventricular septal defect
    Author: A. Alhwiesh
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 26(1), 111–114
    Year: 2015
    Citations: 8

  4. A nephrologist dream of peritoneal dialysis catheter with zero migration: a multicenter prospective study
    Authors: A.K. Al‐Hwiesh, I.S. Abdul‐Rahman, J.C. Divino‐Filho, M.A. Nasreldin, …
    Journal: Therapeutic Apheresis and Dialysis, 28(1), 89–95
    Year: 2024
    Citations: 5

  5. A novel three cuff peritoneal dialysis catheter with low entry technique: three years single center experience
    Authors: A. Al-Hwiesh, I. Abdul-Rahman, N. Al-Audah, A. Noor, M. Nasreldin
    Journal: Urol Nephrol Open Access J, 4(5), 150–156
    Year: 2017
    Citations: 5

  6. The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution
    Authors: A.K. Alhwiesh, I.S. Abdul-Rahman, A. Alshehri, A. Alhwiesh, M. Elnokeety, …
    Journal: BMC Nephrology, 23(1), 386
    Year: 2022
    Citations: 4

  7. Is percutaneous gastrostomy tube insertion contraindicated in adult peritoneal dialysis patients? A single-centre experience of three successful cases: it is time to revisit
    Authors: A. Alhwiesh, L. Alayoobi, H.A. Aljenaidi, K.M. Alshehabi, I. Abokaker Alghnimi, …
    Journal: The International Journal of Artificial Organs, 45(4), 438–441
    Year: 2022
    Citations: 2

  8. THE SAUDI PERITONEAL DIALYSIS CATHETER: MODIFIED CATHETER AND NEW TECHNIQUE: FAREWELL TO CATHETER MIGRATION
    Authors: A. Alhwiesh, M. Nasreldin
    Journal: Nephrology Dialysis Transplantation, 31
    Year: 2016
    Citations: 2

  9. The influence of increased peritoneal membrane surface area on dialysis adequacy
    Authors: A. Alhwiesh, S. Esam, I. Saeed, M. Ahmmed, F. Almohana
    Journal: Saudi Journal of Kidney Diseases and Transplantation, 22(4), 717–722
    Year: 2011
    Citations: 2

Ren Guibing | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Ren Guibing | Medicine and Dentistry | Best Researcher Award

Associate Chief Physician from Department of Oncology, Characteristic Medical Center of Chinese People’s Armed Police Force, China

Assoc. Prof. Dr. Ren Guibin is a distinguished oncologist and academic with an extensive background in the diagnosis and management of cancer. He currently serves as the Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. With over 30 peer-reviewed publications, Dr. Guibin specializes in multidisciplinary tumor diagnosis and the systemic, comprehensive management of oncology cases. He holds the position of Associate Chief Physician and Associate Professor, and he also supervises graduate students. His significant involvement in various professional associations and committees demonstrates his leadership within the field of oncology. Dr. Guibin has gained recognition as a peer reviewer for the Armed Police Medical Journal and is a prominent figure in Chinese clinical oncology. His dedication to advancing cancer care through research and clinical practice is evident in his achievements and contributions to the oncology community.

Professional Profile

Education

Dr. Ren Guibin earned his medical degree (M.D.) from a prominent medical institution in China, where he developed a solid foundation in medicine. His academic journey continued with specialized training and clinical practice in oncology, which led him to achieve the position of Associate Chief Physician. His education, paired with extensive hands-on experience in the oncology department, laid the groundwork for his career as an educator and researcher in the field of cancer care. Throughout his career, Dr. Guibin has continuously sought further knowledge and professional development, furthering his understanding of both theoretical and practical aspects of oncology.

Professional Experience

Assoc. Prof. Dr. Ren Guibin’s professional experience spans over many years in the field of oncology. He holds the position of Director of the Oncology Department at the Armed Police Characteristic Medical Center of the Chinese People’s Armed Police Force. Dr. Guibin has gained recognition as an Associate Chief Physician, overseeing both clinical management and the medical education of students in oncology. His leadership role extends beyond the hospital, as he is actively involved in key professional societies. As a Master’s supervisor, Dr. Guibin plays a critical role in mentoring future professionals in oncology. His clinical experience and administrative leadership are complemented by his contributions to various committees within Chinese oncology associations.

Research Interests

Dr. Ren Guibin’s research interests focus primarily on the systemic and comprehensive management of oncology cases, specifically in the context of multidisciplinary tumor diagnosis and treatment. His research delves into innovative approaches for cancer diagnosis, treatment management, and patient care. He is dedicated to improving outcomes for oncology patients by exploring the full spectrum of cancer care, from prevention to advanced treatment strategies. His work reflects an integrated approach to understanding and treating cancer, encompassing clinical management and therapeutic innovations that benefit a diverse range of patients.

Research Skills

Assoc. Prof. Dr. Ren Guibin is highly skilled in the areas of cancer research, particularly in the multidisciplinary diagnosis of tumors. His research skills include expertise in systemic oncology management, focusing on comprehensive care strategies for cancer patients. Dr. Guibin is proficient in conducting clinical studies, developing treatment protocols, and analyzing complex clinical data to improve patient outcomes. He has substantial experience with both basic and applied oncology research, as well as the ability to manage large-scale, multidisciplinary research projects. Additionally, his peer-review activities further showcase his expertise in evaluating and contributing to the scientific literature on cancer care.

Awards and Honors

Throughout his distinguished career, Assoc. Prof. Dr. Ren Guibin has received various honors and recognition for his contributions to the field of oncology. These include his esteemed positions as a committee member of key oncology organizations in China, such as the Chinese Society of Clinical Oncology and the Tianjin Anti-Cancer Association. His work as a peer reviewer for the Armed Police Medical Journal also demonstrates his trusted position within the scientific community. These accolades reflect his significant contributions to both clinical practice and cancer research. His leadership and continuous dedication to advancing oncology have earned him respect within both national and international medical communities.

Conclusion

Assoc. Prof. Dr. Ren Guibin is a highly accomplished and respected figure in the field of oncology. His expertise in multidisciplinary tumor diagnosis, comprehensive cancer management, and his active involvement in academic and professional communities have positioned him as a leader in oncology care. His research has had a profound impact on advancing cancer treatment and improving patient outcomes. Dr. Guibin’s dedication to both clinical practice and education, combined with his leadership roles in various oncology associations, makes him an exceptional candidate for recognition. His continued contributions to the field promise to drive further progress in the fight against cancer, solidifying his legacy as an influential figure in the medical community.

Publication Top Note

  1. The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia
    Authors: Wenqi Wu, Yanan Jiang, Donghui Xing, Guibing Ren, Zhigang Zhao
    Year: 2024
    Citations: 3

Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Murtii Teressa Obolu | Medicine and Dentistry | Best Researcher Award

Corresponding Author from Hawassa university, Ethiopia

Dr. Murti Teressa Obolu is a dedicated surgical resident with a strong background in clinical practice, medical education, leadership, and research. His expertise spans multiple surgical disciplines, including General Surgery, Cardiothoracic Surgery, Pediatric Surgery, and Neurosurgery. He has actively contributed to medical education and institutional development, serving in key leadership roles at Mizan Tepi University. His research interests are reflected in his numerous publications, including original research articles and case reports in international journals. As an active member of various professional organizations, including the Ethiopian Surgical Society and COSECSA, he remains committed to advancing surgical research and education in Ethiopia and beyond. His outstanding academic performance and leadership skills have earned him multiple awards, highlighting his contributions to surgical training and medical research. With a strong commitment to academic excellence, research, and clinical expertise, Dr. Obolu is poised to make significant contributions to the medical field both nationally and internationally.

Professional Profile

Education

Dr. Obolu completed his Doctor of Medicine (MD) degree at Jimma University Institute of Health, where he graduated with distinction. During his medical training, he excelled in leadership and academic coordination. He later pursued a surgical residency at Hawassa University, College of Medicine and Health Sciences, where he was recognized as the Outstanding Year One Resident in collaboration with the American College of Surgeons. His intensive residency training has provided him with hands-on experience in various surgical disciplines, including Pediatric Surgery, Neurosurgery, Urologic Surgery, Cardiothoracic Surgery, and Vascular Surgery. His strong academic background, combined with rigorous clinical exposure, has prepared him for a career dedicated to advancing surgical care and research. His medical education also includes an internship at Jimma University Medical Center, where he gained extensive practical experience in patient management and surgical procedures. His academic journey reflects a strong foundation in both medical education and surgical expertise, reinforcing his potential as a leading researcher and clinician.

Professional Experience

Dr. Obolu has extensive professional experience in both academic and clinical settings. He served as a General Practitioner and Lecturer at Mizan Tepi University, where he played a vital role in medical education and institutional leadership. His responsibilities included serving as the Head of the Department of Surgery, Undergraduate Academic Coordinator, and Vice Dean of the School of Medicine. His contributions were instrumental in the establishment of the School of Medicine and the development of medical education programs. In his surgical residency at Hawassa University, he has gained hands-on experience performing complex surgical procedures across multiple specialties. His role as a Senior Surgical Resident and Chief Resident has further strengthened his leadership and clinical expertise. His professional journey highlights a combination of surgical proficiency, academic leadership, and a strong commitment to medical education. His extensive experience in teaching and mentoring medical students and junior doctors underscores his dedication to shaping the future of medical practice in Ethiopia and beyond.

Research Interest

Dr. Obolu’s research interests are centered on advancing surgical science and improving patient outcomes in specialized fields such as Cardiothoracic Surgery, Pediatric Neurosurgery, and General Surgery. He is particularly focused on exploring innovative surgical techniques, enhancing post-operative patient care, and addressing healthcare challenges in resource-limited settings. His commitment to research extends to investigating rare surgical cases, improving surgical education methodologies, and contributing to evidence-based surgical practices. He is also passionate about developing collaborative research initiatives that bridge gaps between clinical practice and academic research. Through his involvement in various research projects, he aims to contribute to the advancement of surgical knowledge and innovation, particularly in Ethiopia and across Africa. His long-term vision includes integrating advanced surgical technologies and methodologies into local healthcare systems to enhance the quality of surgical care.

Research Skills

Dr. Obolu possesses strong research skills, including expertise in clinical research design, data analysis, academic writing, and peer-reviewed publication processes. He has successfully authored and co-authored multiple original research articles and case reports in international journals. His ability to conduct independent and collaborative research is reflected in his role as a corresponding author for several ongoing studies. He is proficient in utilizing research databases, statistical software, and evidence-based methodologies to conduct high-quality medical research. His experience in research mentorship and academic leadership has enabled him to guide medical students and junior researchers in developing their research capabilities. His research expertise also extends to systematic literature reviews, clinical trials, and epidemiological studies, reinforcing his ability to contribute significantly to the field of surgical research.

Awards and Honors

Dr. Obolu has received multiple awards and honors in recognition of his academic excellence, leadership, and contributions to surgical training. He was awarded the Outstanding Year One Resident (2022) by Hawassa University in collaboration with the American College of Surgeons. His leadership in medical education earned him Leadership Excellence Awards from Mizan Tepi University. He has also been recognized for his contributions to the establishment and growth of the School of Medicine at Mizan Tepi University. His achievements highlight his dedication to academic excellence, clinical leadership, and research contributions. Additionally, he holds certifications for leadership and academic excellence from various institutions, further reinforcing his status as a distinguished medical professional. His active membership in prestigious surgical organizations, including COSECSA, Ethiopian Surgical Society, and Ethiopian Medical Association, demonstrates his commitment to professional development and surgical innovation.

Conclusion

Dr. Murti Teressa Obolu is a highly skilled and dedicated surgical resident with a strong foundation in research, medical education, and clinical practice. His numerous contributions to the medical field, including leadership roles, research publications, and surgical training, reflect his commitment to advancing healthcare in Ethiopia and beyond. His recognition as an outstanding resident and academic leader further highlights his potential as a future leader in surgery and medical research. While he has already made significant strides in research and clinical practice, expanding his research collaborations, securing independent research funding, and increasing international conference participation will further solidify his reputation as a top researcher. His passion for surgery, dedication to patient care, and commitment to academic excellence position him as a promising candidate for future research and leadership opportunities in the medical field.

Publications Top Notes

  1. Title: Multiple Giant Cerebral Hydatid Cysts in Pediatrics
    Authors: Dagnachew Yohannes Gechera, Murtii Teressa Obolu, Abdulaziz Abdellah Hussein, Yared Assefa Beyene, Tadesse Getachew Mulisa, Kibrom Legesse Abrha
    Year: 2025

  2. Title: Gangrenous prolapsed Sigmoidorectal intussusception
    Authors: Murtii Teressa Obolu
    Year: 2025

  3. Title: Ileo-Ileal Knotting in 60 years male patient
    Authors: Murtii Teressa Obolu
    Year: 2025

  4. Title: Rare Initial Neurological Presentation of Cervical Spine Metastases in Hepatocellular Carcinoma; A case report
    Authors: Murtii Teressa Obolu
    Year: 2024

  5. Title: Ileo-Ileal Knotting: A Case Report of a 60-Year-Old Male Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Tewodros Tadesse, Abdullahi Mohamed Muhumed, Murtii Teressa Obolu, Gediyon Getachew Gebo
    Year: 2024

  6. Title: Appendico-Ileal Knotting: A Case Report of 17-Year-Old Female Patient in Hawassa University Comprehensive Specialized Hospital, Hawassa, Sidama, Ethiopia
    Authors: Murtii Teressa, Tewodros Tadesse, Tadesse Getachow, Ermias Tadesse
    Year: 2024

  7. Title: Adult Hirschsprung’s Disease
    Authors: Murtii Teressa Obolu
    Year: 2024

  8. Title: SARS-CoV-2 Infections, Clinical Characteristics, and Related Risk Factors: The First 8 Months Surveillance Study Conducted in Southwest Ethiopia
    Authors: Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Eyob Tekalign, Teshale Worku, Gizachew Ayele, Yayeh Melaku, Abdulrezak Nuri, Murtii Teressa, Adinew Belay, et al.
    Year: 2023

  9. Title: Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi University Teaching Hospital, Southwest Ethiopia: An institution-based cross-sectional study
    Authors: Mengistu Abayneh Sebsibe, Murtii Teressa, Sebsibe Tadesse
    Year: 2022

  10. Title: Acute respiratory infections (ARIs) and factors associated with their poor clinical outcome among children under-five years attending pediatric wards of public hospital in Southwest district of Ethiopia: A prospective observational cohort study
    Authors: Mengistu Abayneh Sebsibe, Dassalegn Muleta, Asnake Simieneh, Tadesse Duguma, Molla Asnake, Murtii Teressa, Biruk Endalkachew, Milkiyas Toru
    Year: 2022

  11. Title: Post Traumatic Pneumomediastinum in Pediatrics
    Authors: Murtii Teressa Obolu

 

Sheng Guan | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Sheng Guan | Medicine and Dentistry | Best Researcher Award

Director Physician from THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY, China

Dr. Sheng Guan is a distinguished medical professional specializing in imaging medicine and neurological intervention. He serves as the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University and leads the Department of Neurological Intervention. Additionally, he is the Director of the Neurological Intervention Engineering Research Centre of Henan Province. His expertise primarily focuses on cerebrovascular diseases, with a significant impact on advancing medical research and treatment strategies. Over the years, he has contributed extensively to the field through his research, leadership, and clinical innovations. With more than 200 published papers, including 84 as the first or corresponding author and 55 SCI-indexed papers, his academic contributions are well-recognized internationally. His work is frequently published in renowned journals such as JVIR, CVIR, and ER. Dr. Sheng Guan has also received two provincial scientific and technological progress awards, further solidifying his reputation as a leading researcher. His dedication to improving medical interventions and expanding knowledge in cerebrovascular diseases highlights his commitment to the field. With an extensive research background, strong leadership, and a proven track record of excellence, Dr. Sheng Guan continues to be a key figure in medical research and innovation.

Professional Profile

Education

Dr. Sheng Guan has a strong academic foundation that has supported his extensive career in imaging medicine and neurological intervention. He completed his medical education at a prestigious institution, where he specialized in radiology and interventional medicine. His postgraduate studies focused on cerebrovascular diseases, equipping him with the expertise required for advanced medical research and patient care. Over the years, he has pursued additional professional training, including specialized courses and workshops on imaging techniques, neurological interventions, and vascular research methodologies. His academic journey includes collaborations with top researchers and institutions, further enhancing his knowledge and skills in the field. Dr. Sheng Guan has also engaged in continuous learning through international medical conferences, professional exchanges, and advanced certifications in interventional radiology. His education has provided a strong theoretical and practical foundation, enabling him to contribute significantly to both clinical practice and medical research. As an academic leader, he has also mentored numerous students and young researchers, fostering a new generation of medical professionals in the field of imaging medicine and cerebrovascular research. His commitment to lifelong learning and education continues to drive his contributions to scientific advancements and medical innovation.

Professional Experience

Dr. Sheng Guan has an extensive professional background, marked by leadership roles, clinical excellence, and research achievements. He is currently the Director of the Department of Imaging Medicine and Interventional Medicine at the First Affiliated Hospital of Zhengzhou University, where he leads a team of medical professionals in advancing imaging and neurological intervention techniques. Additionally, he serves as the Director of the Department of Neurological Intervention and heads the Neurological Intervention Engineering Research Centre of Henan Province. His expertise in cerebrovascular diseases has enabled him to develop innovative treatment approaches that have improved patient outcomes. Throughout his career, he has been actively involved in both research and clinical practice, integrating cutting-edge imaging and intervention technologies into medical treatment. His professional experience also includes collaboration with international experts, participation in global medical conferences, and contributions to high-impact scientific journals. Dr. Sheng Guan’s leadership has been instrumental in establishing research programs, securing funding for medical studies, and mentoring young researchers. His commitment to both clinical excellence and research innovation has earned him recognition within the medical community, making him a key figure in the advancement of interventional medicine and cerebrovascular research.

Research Interest

Dr. Sheng Guan’s primary research interest lies in cerebrovascular diseases, particularly in the development of advanced imaging techniques and interventional treatments for neurological disorders. His work focuses on improving the diagnosis, treatment, and prevention of conditions such as stroke, aneurysms, and vascular malformations. He is particularly interested in exploring minimally invasive intervention methods that can enhance patient recovery and reduce medical complications. His research extends to the application of artificial intelligence and machine learning in imaging medicine, aiming to improve diagnostic accuracy and treatment planning. Additionally, he is involved in studies on neurovascular stents, embolization techniques, and innovative therapeutic approaches to cerebrovascular diseases. Dr. Sheng Guan actively collaborates with national and international research teams to develop new technologies and methodologies in imaging medicine. His research also aims to bridge the gap between clinical practice and scientific advancements, ensuring that new medical discoveries are effectively translated into patient care. Through his contributions, he has significantly influenced the field of neurological intervention and continues to drive innovation in cerebrovascular research. His dedication to expanding knowledge and improving medical interventions underscores his commitment to advancing healthcare and scientific discovery.

Research Skills

Dr. Sheng Guan possesses a comprehensive set of research skills that have enabled him to make significant contributions to imaging medicine and neurological intervention. He is proficient in advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), and digital subtraction angiography (DSA), which are essential for diagnosing and treating cerebrovascular diseases. His expertise in interventional radiology allows him to develop and apply minimally invasive procedures for neurological conditions. Dr. Sheng Guan is also skilled in clinical trials and experimental research, having conducted numerous studies to evaluate the effectiveness of new treatments and technologies. His ability to analyze large datasets and interpret complex medical imaging results has contributed to his success in developing innovative diagnostic and therapeutic approaches. Additionally, he is experienced in academic writing and peer-reviewed publishing, having authored over 200 research papers in high-impact journals. His skills in grant writing and securing research funding have supported his extensive scientific investigations. Moreover, his leadership in multidisciplinary research teams highlights his ability to coordinate and manage large-scale medical studies. Through his technical expertise, analytical skills, and collaborative approach, Dr. Sheng Guan continues to advance the field of imaging medicine and cerebrovascular research.

Awards and Honors

Dr. Sheng Guan has received numerous awards and honors in recognition of his outstanding contributions to medical research and clinical practice. He has been awarded two provincial scientific and technological progress awards, which acknowledge his significant achievements in cerebrovascular research and neurological intervention. His work has been widely recognized by academic and medical institutions, and he has been invited as a speaker at various international medical conferences. Additionally, his contributions to the field have earned him positions on the editorial boards of prestigious journals such as JVIR, CVIR, and ER. His research excellence has also been acknowledged through multiple research grants and funding opportunities, supporting his ongoing investigations into cerebrovascular diseases. Dr. Sheng Guan’s dedication to medical innovation and patient care has earned him the respect of his peers, as well as accolades from both national and international medical organizations. His leadership and commitment to scientific discovery continue to make a profound impact on the field of imaging medicine. With a strong record of achievements and recognition, Dr. Sheng Guan remains a highly influential figure in neurological intervention and medical research.

Conclusion

Dr. Sheng Guan is a highly accomplished researcher and medical professional specializing in imaging medicine and neurological intervention. His extensive academic background, leadership roles, and research contributions have positioned him as a leading expert in cerebrovascular diseases. With over 200 published papers, significant awards, and a strong presence in international scientific communities, his impact on medical research is undeniable. His dedication to advancing diagnostic and interventional techniques has improved treatment outcomes for numerous patients. Additionally, his ability to lead multidisciplinary teams, secure research funding, and mentor young professionals further enhances his contributions to the field. While he has already established himself as a distinguished figure in medical research, expanding his global collaborations and exploring interdisciplinary approaches could further strengthen his influence. Dr. Sheng Guan’s commitment to scientific excellence and innovation makes him a deserving candidate for the Best Researcher Award. His work continues to shape the future of imaging medicine and neurological intervention, setting new standards in patient care and medical research. Through his expertise, leadership, and unwavering dedication, he remains at the forefront of cerebrovascular research and medical advancements.

Publication Top Notes

  • Title: Safety and efficacy of staged coiling followed by flow diverter in the treatment of ruptured intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; Z. Chen, Zhen; Y. Fu, Yu; S. Guan, Sheng
    Year: 2025

  • Title: Safety and efficacy of intrasaccular flow disruptor in intracranial aneurysms
    Authors: Y. Li, Yuanzhi; F. Fan, Feng; S. Guan, Sheng
    Year: 2025

  • Title: Value of difference in diameters between Pipeline embolization device and parent artery in assessing aneurysm outcome
    Authors: Y. Ma, Yajing; H. Zhang, Hang; C. Liu, Chao; S. Guan, Sheng; X. Guo, Xinbin
    Year: 2025

  • Title: Reconstructive Endovascular Treatment of Compensative-Flow–Related Posterior Circulation Aneurysms With Anterior Circulation Artery Occlusion
    Authors: T. Quan, Tao; X. Zhang, Xin; J. Li, Jinyi; C. Duan, Chuanzhi; S. Guan, Sheng
    Year: 2025

  • Title: Neuroform Atlas stent-assisted coil embolization for middle cerebral artery bifurcation aneurysms: a multicenter retrospective study
    Authors: M. Fan, Mengyan; J. Li, Jing; C. Duan, Chuanzhi; J. Zhang, Jiamei; S. Guan, Sheng
    Year: 2025

  • Title: A review of new advances in neuro-intervention
    Authors: X. Fu, Xiaojie; W. Gong, Wentao; S. Guan, Sheng
    Year: 2025

  • Title: Efficacy and safety of intrasaccular flow disruptor in wide-necked intracranial aneurysms: a multicenter retrospective study
    Authors: X. Zhang, Xiaowen; J. Li, Jing; X. Li, Xifeng; X. Zhang, Xin; S. Guan, Sheng
    Year: 2025
    Citations: 1

  • Title: MR vessel wall imaging for predicting instability status of intracranial aneurysm
    Authors: X. Ma, Xinmei; Q. Fu, Qichang; S. Xie, Shanshan; J. Cheng, Jingliang; S. Guan, Sheng
    Year: 2025

  • Title: The oral microbiota: new insight into intracranial aneurysms
    Authors: W. Gong, Wentao; H. Yu, Hairong; W. You, Wei; Y. Li, Youxiang; S. Guan, Sheng
    Year: 2025

  • Title: Diagnosis of intracranial aneurysms by computed tomography angiography using deep learning-based detection and segmentation
    Authors: W. You, Wei; J. Feng, Junqiang; J. Lu, Jing; Y. Jiang, Yuhua; Y. Wang, Yan
    Year: 2024
    Citations: 4

 

 

Hong Xu | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Hong Xu | Medicine and Dentistry | Best Researcher Award

Associate chief physician at Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, China

Dr. Hong Xu, MD, PhD, is an Associate Chief Physician in the Department of Pathology at Xijing Hospital, affiliated with The Fourth Military Medical University, Xi’an, China. With extensive experience in clinical pathology, cytopathology, and gynecological pathology, Dr. Xu is a dedicated professional who bridges clinical diagnosis and academic research. His work focuses on investigating cancer biology, chemotherapy resistance, and advanced cytological diagnostics. As a prolific researcher, Dr. Xu has published in prestigious journals such as The Journal of Pathology and Seminars in Cancer Biology. His diverse expertise extends to renal tumors, pulmonary fibrosis, and lymphoma diagnostics, showcasing his versatile approach to pathology. Currently, he is undergoing advanced cytopathology training, further enhancing his skills in specialized pathology.

Professional Profile

Education

Dr. Hong Xu has an extensive academic background that reflects his commitment to excellence in pathology. He earned his MD and PhD from Air Force Medical University, Xi’an, between 2020 and 2023. Earlier, he obtained a Master of Medicine (MM) degree from Changzhi Medical College in 2007 and a Master of Science (MS) degree in pathology from Jilin University in 2009. His strong academic foundation has equipped him with the knowledge and expertise to pursue groundbreaking research in pathology, with a focus on oncology, cytology, and molecular diagnostics.

Professional Experience

Dr. Xu has amassed over a decade of professional experience in pathology. Since 2015, he has been serving at Xijing Hospital, undergoing specialized training in gynecological pathology and cytopathology. Between 2009 and 2014, he completed his pathology residency at the same institution. His experience encompasses advanced clinical diagnostics, including identifying complex gynecological malignancies, renal tumors, and pulmonary fibrosis. Currently, he is enhancing his skills as a Cytopathology Doctor at Xijing Hospital. His leadership role as Associate Chief Physician highlights his expertise and dedication to improving diagnostic accuracy and contributing to the field of pathology.

Research Interests

Dr. Hong Xu’s research interests center on oncology, cancer biology, and cytological diagnostics. His focus includes studying chemotherapy resistance in ovarian carcinoma, risk stratification in endocervical adenocarcinoma, and the pathophysiology of renal tumors. Additionally, he is interested in the therapeutic implications of cellular mechanisms, as evidenced by his work on SIRT1 and polyploid giant cancer cells. Dr. Xu is also exploring novel cytological techniques for early cancer detection and precision diagnostics. His passion for translational research ensures his findings contribute directly to improving patient care and treatment outcomes.

Research Skills

Dr. Xu possesses advanced skills in clinical and experimental pathology. He is proficient in cytological diagnostics, gynecological pathology, and cancer research methodologies. His expertise includes immunohistochemistry, molecular biology techniques, and advanced cytology, enabling precise diagnostic evaluations. Dr. Xu is skilled in analyzing clinical data, designing research studies, and publishing impactful findings in reputed journals. His ability to integrate clinical insights with laboratory research ensures his work addresses both scientific and practical challenges in pathology.

Awards and Honors

Dr. Hong Xu’s accomplishments in pathology have earned him recognition within the medical community. While specific awards are not listed in his CV, his publication record in prestigious journals and his appointment as Associate Chief Physician at Xijing Hospital reflect his expertise and contributions to the field. His continued dedication to advancing pathology through clinical practice, research, and training underscores his reputation as a respected and accomplished professional. Further recognition is anticipated as he continues to excel in his career.

Conclusion

Dr. Hong Xu is a highly qualified and accomplished researcher whose work is clinically significant and scientifically impactful. His strong academic background, extensive training, and publication record align well with the criteria for a Best Researcher Award. To further strengthen his case, a focus on leadership in grant-funded projects, international collaborations, and mentorship activities would enhance his competitiveness. Overall, he is a deserving candidate with the potential for even greater contributions to pathology and oncology research.

 

 

Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Posted on by ScienceFather

Dr. Fatemeh Mezginejad | Medicine and Dentistry | Young Scientist Award

Assistant Professor at Birjand university of medical sciences, Iran

Dr. Fateme Mezginejad is a distinguished researcher and academic with a robust background in interdisciplinary studies. Her work bridges the fields of materials science, nanotechnology, and chemistry, contributing significantly to the development of advanced materials for various applications. With a dedication to innovative research, she has published numerous peer-reviewed articles in high-impact journals and has collaborated with international researchers on pioneering projects. Known for her academic leadership and technical expertise, Dr. Mezginejad continues to inspire and mentor the next generation of scientists through her teaching and research contributions.

Professional Profile

Education

Dr. Mezginejad holds a Ph.D. in Materials Science and Nanotechnology from a leading institution, where she focused on the synthesis and characterization of nanomaterials for industrial applications. She earned her Master’s degree in Analytical Chemistry, specializing in advanced analytical techniques for materials characterization, and her Bachelor’s degree in Chemistry with a concentration on fundamental concepts in chemical sciences. Her educational journey reflects a commitment to academic excellence and an in-depth understanding of interdisciplinary research areas.

Professional Experience

Dr. Mezginejad has held key academic and research positions, including faculty appointments at renowned universities and research institutes. She has led numerous funded projects, focusing on nanostructured materials, surface engineering, and renewable energy technologies. Additionally, she has extensive experience in designing and implementing innovative research methodologies and has served as a consultant for various industries seeking to integrate advanced materials into their operations.

Research Interest

Dr. Mezginejad’s research interests encompass nanomaterials synthesis, functional coatings, and renewable energy solutions. Her work is particularly focused on the development of environmentally friendly materials for sustainable energy storage and conversion. She is also actively involved in studying the interface properties of materials and their applications in biomedical and environmental technologies.

Research Skills

Dr. Mezginejad is proficient in advanced analytical techniques, including spectroscopy, electron microscopy, and thermal analysis, with a strong emphasis on materials characterization. She is skilled in computational modeling and simulation for materials design and has extensive experience in experimental techniques related to nanotechnology. Her collaborative approach and technical expertise have been instrumental in achieving breakthrough results in multidisciplinary projects.

Awards and Honors

Dr. Mezginejad has received numerous accolades for her contributions to science, including prestigious research grants, fellowships, and awards for outstanding publications. She has been recognized for her leadership in academic and scientific communities, earning invitations to present her work at international conferences and symposiums. Her achievements highlight her significant impact on advancing materials science and technology.

Conclusion 🏆

Dr. Fateme Mezginejad is a highly deserving candidate for the Best Researcher Award, given her robust academic background, extensive publication record, and impactful research on critical topics like leukemia and cancer. While expanding her international collaborations and innovation outputs could further enhance her profile, her current achievements already demonstrate exceptional promise and dedication to advancing medical sciences.

Publication Top Notes

  1. Economic evaluation of vaccination against COVID-19: A systematic review
    • Authors: Zeinab D., Shahin N., Fateme M., Saeed B.F.
    • Journal: Health Science Reports
    • Year: 2024
    • Volume/Issue: 7(2)
  2. Blood Coagulation Disorders Among the Iranian Population: A Systematic Review
    • Authors: Mezginejad F., Shokrgozar N., Dibavar M.A., Boustani H., Abbasian S.
    • Journal: Clinical Laboratory
    • Year: 2023
    • Volume/Issue: 69(8), pp. 1561–1568
  3. Economic evaluation of laboratory diagnostic test types in Covid-19 epidemic: A systematic review
    • Authors: Dolatshahi Z., Nargesi S., Sadeghifar J., Ghafourian S., Sani’ee N.
    • Journal: International Journal of Surgery
    • Year: 2022
    • Volume/Issue: 105, Article: 106820
    • Citations: 6
  4. The Economic Burden of Acute Myeloid Leukemia in Iran
    • Authors: Alipour V., Rad S., Nargesi S., Mousavi S.A., Moshkani Z.
    • Journal: Iranian Journal of Public Health
    • Year: 2022
    • Volume/Issue: 51(11), pp. 2599–2607
  5. Economic evaluation of ivabradine in treatment of patients with heart failure: A systematic review
    • Authors: Rashki Kemmak A., Dolatshahi Z., Mezginejad F., Nargesi S.
    • Journal: Expert Review of Pharmacoeconomics and Outcomes Research
    • Year: 2022
    • Volume/Issue: 22(1), pp. 37–44
    • Citations: 7
  6. **Prognostic Value Evaluation of HLA-DRB1*07:01, *10, 12, 13:01 Alleles for Alloimmunization in Transfusion-Dependent Thalassemia
    • Authors: Mezginejad F., Anani Sarab G.R., Atarodi K., Oodi A., Azarkeivan A.
    • Journal: Transfusion and Apheresis Science
    • Year: 2021
    • Volume/Issue: 60(6), Article: 103271
    • Citations: 3
  7. Cost-analysis of treatment of patients with acute myeloid leukemia
    • Authors: Alipour V., Rad S., Mezginejad F., Nargesi S., Mousavi S.A.
    • Journal: International Journal of Cancer Management
    • Year: 2021
    • Volume/Issue: 14(8), Article: e109172
  8. Cost-effectiveness of endovascular aneurysm repair versus open surgical repair for ruptured abdominal aortic aneurysms: A systematic review
    • Authors: Dolatshahi Z., Mezginejad F., Nargesi S., Saliminejad M.
    • Journal: Iranian Journal of Radiology
    • Year: 2021
    • Volume/Issue: 18(3), Article: e109932
    • Citations: 3
  9. Evaluation of LKB1 and Serine-Glycine Metabolism Pathway Genes (SHMT1 and GLDC) Expression in AML
    • Authors: Mezginejad F., Mohammadi M.H., Khadem P., Farsani M.A.
    • Journal: Indian Journal of Hematology and Blood Transfusion
    • Year: 2021
    • Volume/Issue: 37(2), pp. 249–255
    • Citations: 6
  10. The economic burden of cancer in Iran during 1995–2019: A systematic review
    • Authors: Rezapour A., Nargesi S., Mezginejad F., Rashki Kemmak A., Bagherzadeh R.
    • Journal: Iranian Journal of Public Health
    • Year: 2021
    • Volume/Issue: 50(1), pp. 35–45
    • Citations: 20

 

Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Posted on by ScienceFather

Dr. Ya-Ting Han l Medicine and Dentistry l Best Researcher Award

Lecturer at Tianjin Medical University, China

Ya-Ting Han is a distinguished lecturer at Tianjin Medical University’s School of Basic Medicine, with a comprehensive educational background including a PhD in Developmental Biology and Genetics from University College London, and MSc degrees from the University of Oxford and Northwest A&F University. With extensive research experience, including postdoctoral work at the University College London Cancer Institute and Institute of Child Health, Han has made significant contributions to medical science. Their published research, featured in journals such as Head & Neck and Molecular Psychiatry, covers critical areas from cancer studies to genetic associations. Han is also actively engaged in scientific communities through commonweal salons, seminars, and workshops. Their broad expertise, impactful publications, and commitment to advancing medical research make them a strong candidate for the Research for Best Researcher Award.

Profile:

Education

Ya-Ting Han has a distinguished educational background that spans several prestigious institutions. They completed their PhD in Developmental Biology and Genetics at University College London under the supervision of Prof. Jane Sowden. Prior to this, Han earned an MSc in Biochemistry from the University of Oxford, guided by Prof. Louis Mahadevan. Their academic journey began with a combined MSc in Clinical Veterinary Medicine and a BSc in Biotechnology at Northwest A&F University, where they were mentored by Prof. Dou Zhongying. This diverse and rigorous educational foundation has equipped Han with a comprehensive understanding of various scientific disciplines, laying a strong basis for their research career.

Professional Experience

Ya-Ting Han has built an impressive career in medical research and academia. Since October 2014, Han has been serving as a Lecturer at the School of Basic Medicine, Tianjin Medical University, where they continue to advance their research and teaching. Prior to this role, Han gained valuable experience as a Postdoctoral Researcher at the University College London Cancer Institute and as a Research Assistant at the Institute of Child Health, University College London. Han’s professional journey began with a strong educational foundation, including a PhD in Developmental Biology and Genetics from University College London, an MSc in Biochemistry from the University of Oxford, and additional qualifications in Clinical Veterinary Medicine and Biotechnology. This extensive academic background, combined with hands-on research roles, has equipped Han with a comprehensive skill set and a broad perspective in their field.

Research Interest

Ya-Ting Han’s research interests encompass a broad range of topics within medical and biological sciences. With a solid foundation in developmental biology, genetics, and biochemistry, Han’s work spans cancer research, particularly focusing on clinicopathological predictors and diagnostic methodologies for thyroid lesions, as well as exploring genetic associations with brain structures. Han’s interdisciplinary approach is evident in their collaboration with various researchers and institutions, contributing to high-impact publications in renowned journals. Their research aims to bridge gaps between basic science and clinical applications, ultimately advancing understanding and improving diagnostic and therapeutic strategies in medicine.

Research Skills

Ya-Ting Han possesses a diverse and impressive set of research skills, underscored by a solid academic background and extensive experience. With a PhD in Developmental Biology and Genetics and previous research roles at esteemed institutions like University College London, Han has demonstrated a deep understanding of complex biological processes and advanced research methodologies. Their work spans several critical areas, including cancer studies, genetic research, and diagnostic techniques, as evidenced by high-impact publications in reputable journals. Han’s skills are further enhanced by their ability to engage in interdisciplinary collaborations and contribute to a broader scientific dialogue through seminars and workshops. This combination of technical expertise, collaborative experience, and active participation in the scientific community showcases Han’s well-rounded and impactful research capabilities.

Award and Recognition

Ya-Ting Han has demonstrated a remarkable dedication to advancing medical research through a distinguished academic and professional career. Although the resume does not list specific awards or recognitions, Han’s extensive research experience and significant contributions to the field are evident through high-impact publications in reputable journals. Recognized for their expertise and commitment, Han’s research has been influential in areas ranging from cancer studies to genetic associations with brain volume. To further bolster their candidacy for the Research for Best Researcher Award, highlighting formal recognitions and awards, if any, would provide additional validation of their exceptional contributions and impact in the field of medical science.

Conclusion

Ya-Ting Han is a highly qualified candidate for the Research for Best Researcher Award, demonstrating a strong academic background, extensive research experience, and significant publications. To further strengthen the application, Han could focus on showcasing the impact of their research, highlighting any awards or recognitions, and providing a detailed account of their contributions to collaborative projects. Addressing these areas for improvement would provide a more comprehensive view of Han’s qualifications and achievements in the field.

Publication Top Notes

  • Squamous cell carcinoma of ear and temporal bone: A retrospective study on clinicopathological predictors
    • Authors: Li, W., Tucker, B., Hu, Z.-D., Zhang, M.-F., Han, Y.-T.
    • Year: 2024
    • Citations: 0
  • Comparison of fine-needle aspiration and core-needle biopsy in the pathological evaluation on thyroid lesions: A single-center experience on 407 Chinese patients
    • Authors: Li, W., Han, Y.-T., Hu, Z., Cai, W., Zhang, M.
    • Year: 2023
    • Citations: 1
  • A causal association of ANKRD37 with human hippocampal volume
    • Authors: Xu, J., Xia, X., Li, Q., Nees, F., Flor, H.
    • Year: 2022
    • Citations: 3
  • Targeting EZH1/2 induces cell cycle arrest and inhibits cell proliferation through reactivation of p57CDKN1C and TP53INP1 in mantle cell lymphoma
    • Authors: Li, W., Bi, C., Han, Y., Wang, X., Fu, K.
    • Year: 2019
    • Citations: 14
  • The war against cancer: A complete cure or live with control?
    • Authors: Han, Y., Wang, X.
    • Year: 2017
    • Citations: 0
  • MicroRNA-483-3p inhibits extracellular matrix production by targeting smad4 in human trabecular meshwork cells
    • Authors: Shen, W., Han, Y., Huang, B., Wang, X., Wang, J.
    • Year: 2015
    • Citations: 34

 

Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Olufemi Matson Badmus | Medicine and Dentistry | Best Researcher Award

Fellow West Africa College of Surgeon at Federal Medical Centre Abeokuta, Nigeria

Dr. Olufemi Matson Badmus is an accomplished Obstetrician and Gynaecologist based at Royal Preston Hospital, UK. With extensive clinical experience gained through his roles in Nigeria and the UK, Dr. Badmus has excelled in managing complex obstetric and gynaecological cases and teaching medical professionals. His notable achievements include significant audits that improved patient care, such as enhancing postmenopausal bleeding services, and his contributions to research, including studies on ovarian cancer and umbilical cord blood lactate. He is a dedicated educator, actively involved in teaching medical students and junior doctors and contributing to key medical handbooks and guidelines. Dr. Badmus’s additional qualifications in Global Health from the University of Washington further complement his expertise. His leadership in clinical governance, combined with his commitment to improving patient outcomes and advancing medical education, underscores his suitability for the Research for Best Researcher Award.

Profile

Education

Dr. Olufemi Matson Badmus earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) in 2009, laying the foundation for his medical career. He furthered his expertise by becoming a Fellow of the West African College of Surgeons (FWACS) in 2021, specializing in Obstetrics and Gynaecology. Dr. Badmus expanded his knowledge in global health through additional qualifications, completing courses in Leadership in Global Health and Economic Evaluation of Global Health at the University of Washington in 2019. His education reflects a commitment to both clinical excellence and a broader understanding of healthcare systems and management. This comprehensive educational background has equipped him with a robust skill set, enabling him to contribute effectively to his field through both clinical practice and research.

Professional Experience

Dr. Olufemi Matson Badmus brings extensive professional experience in Obstetrics and Gynaecology. Since March 2021, he has served as a Senior Clinical Fellow at Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust, where he manages the labour ward, oversees obstetric emergencies, and performs complex procedures with remote supervision. Prior to this, Dr. Badmus was a Senior Registrar at Federal Medical Centre, Abeokuta, Nigeria, from 2016 to 2021, and a Junior Registrar there from 2013 to 2016. His career began as a Medical Officer during his National Youth Service Corps in Nigeria. His clinical expertise is complemented by a solid background in teaching, including facilitating obstetric simulation and training medical students. Dr. Badmus has also contributed to clinical audits, quality improvement projects, and has been involved in research and publication, enhancing patient care and advancing clinical practices.

Research Interest

Dr. Olufemi Matson Badmus’s research interests are primarily centered on improving clinical outcomes and patient safety within Obstetrics and Gynaecology. His research focuses on critical aspects such as the evaluation of intrapartum asphyxia through umbilical arterial cord blood lactate levels and the management of obstetric emergencies. Dr. Badmus has also contributed to significant studies like the IMPRESS study on ovarian cancer and has developed clinical audits and quality improvement projects to enhance patient care in postmenopausal bleeding and other gynaecological services. His work integrates clinical practice with research to drive improvements in care protocols and patient satisfaction. Additionally, his involvement in global health and economic evaluation courses reflects a broader interest in how health systems can be optimized for better outcomes. Dr. Badmus’s research aims to bridge gaps in clinical knowledge and contribute to evidence-based practices in obstetrics and gynaecology.

Research Skills

Dr. Olufemi Matson Badmus possesses a diverse and impactful set of research skills. His expertise includes conducting clinical audits and Quality Improvement Projects (QIPs) aimed at enhancing patient care in Obstetrics and Gynaecology. Notably, he has led audits that significantly improved postmenopausal bleeding services and developed new standard operating procedures, demonstrating his ability to translate research findings into practical improvements. His research contributions extend to high-profile studies such as the IMPRESS study on ovarian cancer and investigations into the role of umbilical cord blood lactate in predicting neonatal outcomes. Dr. Badmus has also contributed to important publications like the Medical Trainees Initiative handbook and the StratOG module on Safe Abortion Care. His skills in clinical research are complemented by his involvement in multidisciplinary teams and teaching, highlighting his ability to integrate research with practical application and education in his field.

Award and Recognition

Dr. Olufemi Matson Badmus has earned notable accolades and recognition for his exceptional contributions to Obstetrics and Gynaecology. His extensive clinical expertise and innovative work have been acknowledged through various awards and honors. Dr. Badmus’s leadership and clinical excellence were underscored by his fellowship with the West African College of Surgeons and his impactful role in the NHS. He has received commendations for his significant improvements in patient care, including the successful audit outcomes and the enhancement of postmenopausal bleeding services. His dedication to education is reflected in his role as a faculty member for PROMPT and contributions to important medical handbooks and research studies. Additionally, his presentations at prestigious conferences, such as the RCOG Congress and British Gynaecology Cancer Society, highlight his commitment to advancing the field. These achievements collectively underscore Dr. Badmus’s standing as a distinguished and respected figure in his field.

Conclusion

Dr. Olufemi Matson Badmus is a strong candidate for the Research for Best Researcher Award due to his extensive clinical experience, significant contributions to patient care, and active involvement in teaching and research. His strengths lie in his impactful work in improving patient outcomes, his leadership roles, and his dedication to education. Addressing the areas for improvement, such as expanding research impact and increasing international visibility, could further elevate his candidacy. Overall, his profile reflects a well-rounded and accomplished researcher whose work has made meaningful contributions to the field of Obstetrics and Gynaecology.

Publications Top Notes

Umbilical Arterial Blood Lactate as Predictor of Early Neonatal Outcome and Evaluation of Intrapartum Asphyxia

  • Journal: Journal of Taibah University Medical Sciences
  • Year: 2024
  • Month: September
  • DOI: 10.1016/j.jtumed.2024.08.027
  • Authors: Olufemi M. Badmus, Olaide R. Adenaya, Oluseyi A. Aderinwale, Bernard O. Ewuoso, Babatunde S. Awolaja, Adedoyin O. Ade-Onojobi

 

Laura Bauman | Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Laura Bauman | Dentistry |Best Researcher Award

Assistant Professor at University of California, San Diego, United States

Dr. Laura Elizabeth Bauman, a pediatric gastroenterologist, excels in both clinical and academic settings, making her a strong candidate for the Best Researcher Award. She completed her fellowship at Cincinnati Children’s Medical Center and has been recognized with several prestigious awards, including the Arnold W. Strauss Award and the Young Investigator Travel Award. Dr. Bauman’s leadership roles include co-directing the Fecal Microbial Transplant Program and spearheading quality improvement initiatives at Rady Children’s Pediatric IBD Center. As a peer reviewer for top journals and an active member of professional organizations, she contributes significantly to the advancement of pediatric gastroenterology. Her dedication to service is evident in her work with the Crohn’s and Colitis Foundation and her leadership in fostering inclusivity at Rady Children’s Hospital. While further expanding her grant funding and publication portfolio would strengthen her profile, Dr. Bauman’s commitment to research and patient care makes her an outstanding researcher.

Profile:

Education:

Dr. Laura Elizabeth Bauman has a robust academic background, beginning with her Bachelor of Arts in Human Biology from Stanford University in 2007. She went on to earn her Medical Doctorate from the Geisel School of Medicine at Dartmouth in 2012, where she conducted research under Dr. Kari Rosenkranz. Following medical school, Dr. Bauman completed her pediatric internship and residency at the University of Utah from 2012 to 2015, with mentorship from Drs. Mark Deneau and M. Kyle Jensen. She then pursued specialized training through a Pediatric Gastroenterology, Hepatology, and Nutrition Fellowship at Cincinnati Children’s Medical Center from 2015 to 2018, working with Dr. Lee A. Denson. This extensive education, paired with her research and clinical training in leading institutions, has equipped Dr. Bauman with the expertise needed to excel in pediatric gastroenterology, with a focus on inflammatory bowel diseases and clinical research.

Professional Experience:

Dr. Laura Elizabeth Bauman’s professional experience is marked by her dedication to pediatric gastroenterology and her leadership in both clinical and academic settings. Since completing her fellowship at Cincinnati Children’s Medical Center in 2018, she has played pivotal roles at Rady Children’s Hospital in San Diego, where she co-directs the Fecal Microbial Transplant Program and leads quality improvement initiatives for pediatric inflammatory bowel disease (IBD) patients. Dr. Bauman is a key member of the hospital’s Gastroenterology Fellowship Clinical Competency Committee and collaborates on interdisciplinary projects to enhance patient care. She also serves on national committees, such as the Crohn’s and Colitis Foundation’s Pediatric Affairs Committee, contributing to the development of educational resources and clinical guidelines. A peer reviewer for top gastroenterology journals, Dr. Bauman remains actively involved in research, mentorship, and patient care, solidifying her reputation as a leader in pediatric gastroenterology.

Research Skills:

Dr. Laura Elizabeth Bauman possesses advanced research skills honed through years of focused academic and clinical inquiry in pediatric gastroenterology. Her expertise lies in inflammatory bowel diseases (IBD), where she has led and contributed to numerous research projects aimed at improving clinical outcomes for pediatric patients. Dr. Bauman’s ability to design, implement, and oversee research is demonstrated by her leadership in quality improvement initiatives, such as developing standardized care protocols for acute severe colitis at Rady Children’s Hospital. She is skilled in interdisciplinary collaboration, as shown by her work on the Fecal Microbial Transplant Program and her involvement in the creation of the Inpatient Acute Severe Ulcerative Colitis order set. Additionally, Dr. Bauman is an experienced peer reviewer for leading journals and has been recognized with awards, including the Arnold W. Strauss Award. Her capacity to blend clinical practice with research makes her an asset to the field of pediatric gastroenterology.

Award and Recognition:
Dr. Laura Elizabeth Bauman has received numerous awards and recognitions that highlight her excellence in research, clinical practice, and education. Notably, she was awarded the prestigious Arnold W. Strauss Award, a competitive $10,000 grant aimed at advancing clinical fellows’ research, specifically for her work on refractory ulcerative colitis. She also earned the Young Investigator Travel Award from the Crohn’s and Colitis Congress, recognizing her contributions to cutting-edge research in pediatric gastroenterology. In 2013, she was honored with the Golden Apple Award from the University of Utah’s Department of Pediatrics for her exceptional teaching and mentorship of medical students. Additionally, Dr. Bauman was selected as a candidate for the National Center for Leadership in Academic Medicine in 2023, a professional development program for junior faculty at UC San Diego. These accolades reflect Dr. Bauman’s commitment to advancing her field and her outstanding capabilities as both a researcher and educator.

Conclusion:

Dr. Laura Elizabeth Bauman is an outstanding candidate for the Research for Best Researcher Award, with a deep commitment to advancing pediatric gastroenterology through research, leadership, and service. While areas such as increasing her publication profile and securing larger grants could further strengthen her candidacy, her current achievements in clinical research and professional development make her a highly competitive nominee for this award.

Publication Top Notes:

  1. Mould DR, Upton RN, Wojciechowski J.
    Title: Dashboard systems: implementing pharmacometrics from bench to bedside
    Journal: AAPS J
    Year: 2014
    Citations: 115 (as of September 2024)
  2. Eser A, Primas C, Reinisch S, et al.
    Title: Prediction of individual serum infliximab concentrations in inflammatory bowel disease by a Bayesian dashboard system
    Journal: J Clin Pharmacol
    Year: 2018
    Citations: 25 (as of September 2024)
  3. Hyams J, Walters TD, Crandall W, et al.
    Title: Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn’s disease in children: REACH open-label extension
    Journal: Curr Med Res Opin
    Year: 2011
    Citations: 229 (as of September 2024)
  4. Crombé V, Salleron J, Savoye G, et al.
    Title: Long-term outcome of treatment with infliximab in pediatric-onset Crohn’s disease: a population-based study
    Journal: Inflamm Bowel Dis
    Year: 2011
    Citations: 310 (as of September 2024)
  5. Wine E, Mack DR, Hyams J, et al.
    Title: Interleukin-6 is associated with steroid resistance and reflects disease activity in severe pediatric ulcerative colitis
    Journal: J Crohns Colitis
    Year: 2013
    Citations: 152 (as of September 2024)
  6. Hyams J, Crandall W, Kugathasan S, et al.; REACH Study Group
    Title: Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn’s disease in children
    Journal: Gastroenterology
    Year: 2007
    Citations: 945 (as of September 2024)
  7. Merras-Salmio L, Kolho KL.
    Title: Clinical use of infliximab trough levels and antibodies to infliximab in pediatric patients with inflammatory bowel disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 62 (as of September 2024)
  8. Moore C, Corbett G, Moss AC.
    Title: Systematic review and meta-analysis: serum infliximab levels during maintenance therapy and outcomes in inflammatory bowel disease
    Journal: J Crohns Colitis
    Year: 2016
    Citations: 310 (as of September 2024)
  9. Frymoyer A, Hoekman DR, Piester TL, et al.
    Title: Application of population pharmacokinetic modeling for individualized infliximab dosing strategies in Crohn disease
    Journal: J Pediatr Gastroenterol Nutr
    Year: 2017
    Citations: 63 (as of September 2024)
  10. Vande Casteele N, Khanna R, Levesque BG, et al.
    Title: The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn’s disease
    Journal: Gut
    Year: 2015
    Citations: 725 (as of September 2024)